• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Nasal Polyps

Nasal Polyps - 33 Studies Found

Completed : Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps
:
  • Sinusitis
  • Nasal Polyps

: 2017-02-14
: Drug: Verapamil Hydrochloride Intranasal Verapamil solution for injection, supplied in vials, will be ut
Completed : Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps
: Chronic Sinusitis With or Without Nasal Polyps
: 2012-06-14
: Drug: Fluticasone Propionate Fluticasone Propionate 400 μg
Completed : Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial
:
  • Chronic Rhinosinusitis
  • Nasal Polyps

: 2010-09-08
:
  • Drug: placebo during 56 days

Completed : Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis
:
  • Chronic Rhinosinusitis
  • Nasal Polyps

: 2010-02-08
:
  • Drug: Xolair placebo two to fo

NOT_YET_RECRUITING : Identifying Predictors Of Response To Mepolizumab In CRSwNP
:
: 2025-08-02
: Patients will receive Mepolizumab 100mg SC once every 4 weeks for 48 weeks (twelve injections, no placebo) at the hospital.The IMP will be admin
NOT_YET_RECRUITING : The Role of IL5 in Epithelial Cell Integrity
:
: 2025-08-02
: In vitro exposure of human nasal epithelial cells to mepolizumab
NOT_YET_RECRUITING : Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps
:
: 2025-08-02
: SHR-1905 Injection
Completed : A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
: Chronic Rhinosinusitis With Nasal Polyps
: 2025-08-02
: Verekitug (UPB-101) 0.5 mL of formulated solution (100 mg verekitug [UPB-101])
NOT_YET_RECRUITING : Early-onset Dupilumab Effects in CRSwNP
: Chronic Rhinosinusitis With Nasal Polyps
: 2025-08-02
: Two injections of 300mg dupilumab, subcutaneous 14 days apart
Completed : Mechanisms of Smell Improvement With Dupilumab.
: Chronic Rhinosinusitis With Nasal Polyps
: 2025-08-02
: Monoclonal antibody blocking interleukin 4 and interleukin 13
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.